Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cidara Thera (CDTX)

Cidara Thera (CDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Halper Sadeh LLC Encourages GIFI, MOVE, RMBI, CDTX Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

RMBI : 14.02 (-0.99%)
GIFI : 11.90 (+0.17%)
MOVE : 8.86 (-9.13%)
CDTX : 220.50 (-0.22%)
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - EXAS, SEE, CDTX, and MRSN

NEW YORK , Nov. 27, 2025 / PRNewswire/ --

SEE : 42.28 (-0.45%)
MRSN : 27.47 (-1.36%)
EXAS : 101.13 (-0.12%)
CDTX : 220.50 (-0.22%)
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations

Target enrollment of 6,000 participants completed in the Northern Hemisphere Planned interim analysis in Q1 2026 will determine potential need for additional enrollment during Southern Hemisphere...

CDTX : 220.50 (-0.22%)
SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-NUVSF, NDTAF, THS, and CDTX

NEW YORK , Nov. 21, 2025 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of...

NUVSF : 13.5400 (+0.30%)
NDTAF : 19.9200 (+42.29%)
CDTX : 220.50 (-0.22%)
THS : 23.73 (-0.88%)
Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything

Merck's multi-billion-dollar acquisition of Cidara Therapeutics is a strategic move to secure a new era of growth with a high-potential antiviral asset.

MRK : 100.89 (-1.35%)
CDTX : 220.50 (-0.22%)
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

SEE : 42.28 (-0.45%)
MRSN : 27.47 (-1.36%)
RPTX : 2.23 (+2.76%)
CDTX : 220.50 (-0.22%)
Cidara Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cidara Therapeutics, Inc. - CDTX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Cidara Therapeutics...

MRK : 100.89 (-1.35%)
CDTX : 220.50 (-0.22%)
Stocks Settle Mixed as Fed Comments Suggest a Rate Cut Pause

The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. December E-mini...

GOOGL : 317.62 (-0.63%)
MPC : 190.15 (+0.38%)
AAPL : 280.70 (-1.21%)
CVX : 152.26 (+0.44%)
ADI : 277.26 (-0.35%)
NU : 17.65 (+1.20%)
STUB : 11.93 (+10.67%)
TXN : 180.12 (-1.36%)
$IUXX : 25,581.70 (-0.10%)
DASH : 221.19 (-0.58%)
ASML : 1,110.08 (-2.70%)
ZNH26 : 112-260 (+0.08%)
Halper Sadeh LLC Encourages CDTX, MRSN, HOLX Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

HOLX : 74.86 (-0.20%)
MRSN : 27.47 (-1.36%)
CDTX : 220.50 (-0.22%)
Stocks Recover on Strength in Megacap Tech and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.11%. December E-mini S&P futures...

MSTR : 186.01 (-1.26%)
GOOGL : 317.62 (-0.63%)
MPC : 190.15 (+0.38%)
AAPL : 280.70 (-1.21%)
GLXY : 27.57 (+1.92%)
NU : 17.65 (+1.20%)
STUB : 11.93 (+10.67%)
$IUXX : 25,581.70 (-0.10%)
COIN : 274.05 (-1.04%)
ZNH26 : 112-260 (+0.08%)
MSFT : 480.84 (+0.65%)
OXY : 42.67 (+0.52%)

Barchart Exclusives

Is This Dividend Stock a Buy for 2026 After Rising 265% in 2025?
Anglogold Ashanti shares have soared this year amid a spike in gold prices. While the shares might take a breather for now, it is a buy-on-the-dip candidate for 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar